Irvine, CA, United States of America

Ronald Dieck


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Ronald Dieck

Introduction

Ronald Dieck is a notable inventor based in Irvine, California. He has made significant contributions to the field of biomedicine, particularly in the development of processes that enhance the safety and efficacy of implantable medical devices. His work has implications for improving patient outcomes in various medical applications.

Latest Patents

Dieck holds a patent for a process aimed at decreasing residual aldehyde levels in implantable bioprosthetic tissue. The patent describes a method where residual aldehyde levels are reduced by contacting the tissue with a rinsing solution. This solution facilitates the diffusion of aldehyde out of the tissue, allowing it to react with an amine, which can either be dissolved in the rinsing solution or immobilized on a solid support. This innovative approach addresses a critical concern in the use of bioprosthetic materials.

Career Highlights

Ronald Dieck is associated with Baxter Travenol Laboratories, Inc., a company known for its advancements in medical technology and pharmaceuticals. His work at Baxter has allowed him to focus on developing solutions that enhance the safety of medical implants. With a patent portfolio that includes 1 patent, Dieck has established himself as a valuable contributor to the field.

Collaborations

Dieck has collaborated with Aws S Nashef, a fellow professional in the industry. Their partnership exemplifies the collaborative spirit that drives innovation in medical technology.

Conclusion

Ronald Dieck's contributions to the field of biomedicine, particularly through his patented process for reducing aldehyde levels in bioprosthetic tissue, highlight his commitment to improving medical devices. His work continues to influence the development of safer and more effective implantable technologies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…